Estimating risks and benefits in AIDS vaccine and drug trials.
作者信息
Kessel Elton
出版信息
AIDS Public Policy J. 1990 Winter;5(4):186-8.
PMID:11650977
Abstract
摘要
相似文献
1
Estimating risks and benefits in AIDS vaccine and drug trials.
AIDS Public Policy J. 1990 Winter;5(4):186-8.
2
The paradoxical case of payment as benefit to research subjects.
IRB. 1989 Nov-Dec;11(6):1-3.
3
Some ethical issues associated with HIV vaccine trials.
AIDS Public Policy J. 1988 Summer;3(3):46-8.
4
The ethics of phase I pediatric oncology trials.
IRB. 1995 Jan-Feb;17(1):1-5.
5
Considering experimentation and elusive truth: informed consent made difficult.
Issues (St Louis Mo). 1992 Mar-Apr;7(2):1-8.
6
The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
IRB. 1998 Mar-Jun;20(2-3):1-5.
7
Approving high risk, rejecting low risk: the case of two cases.
IRB. 1985 Jan-Feb;7(1):6-8.
8
Women and HIV/AIDS research: the barriers to equity.
IRB. 1991 Jan-Apr;13(1-2):18-22.
9
Protectionism and the new research imperative in pediatric AIDS.
IRB. 1990 Sep-Oct;12(5):1-5.
10
Ethical considerations in AIDS vaccine testing.
IRB. 1989 May-Jun;11(3):1-4.
Zotero 插件